Insufficient scRNA-seq data for expression of ALG10 at single-cell level.
Insufficient scRNA-seq data for expression of ALG10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 157.44 | 180 / 180 | 100% | 3.96 | 428 / 430 |
esophagus | 100% | 103.14 | 1441 / 1445 | 99% | 4.79 | 182 / 183 |
lung | 99% | 121.98 | 575 / 578 | 98% | 4.05 | 1134 / 1155 |
breast | 100% | 153.94 | 459 / 459 | 97% | 3.83 | 1085 / 1118 |
prostate | 100% | 117.90 | 245 / 245 | 96% | 3.24 | 484 / 502 |
uterus | 100% | 145.91 | 170 / 170 | 96% | 3.85 | 442 / 459 |
thymus | 100% | 153.94 | 653 / 653 | 94% | 2.47 | 570 / 605 |
stomach | 100% | 105.96 | 359 / 359 | 94% | 3.28 | 269 / 286 |
bladder | 100% | 119.62 | 21 / 21 | 93% | 3.13 | 469 / 504 |
intestine | 100% | 107.22 | 964 / 966 | 92% | 2.78 | 484 / 527 |
pancreas | 98% | 115.83 | 323 / 328 | 88% | 2.09 | 156 / 178 |
skin | 100% | 174.83 | 1806 / 1809 | 86% | 2.29 | 405 / 472 |
kidney | 99% | 78.79 | 88 / 89 | 85% | 2.30 | 764 / 901 |
brain | 89% | 50.98 | 2350 / 2642 | 84% | 1.69 | 589 / 705 |
liver | 99% | 71.57 | 224 / 226 | 59% | 1.10 | 239 / 406 |
adrenal gland | 100% | 152.64 | 258 / 258 | 50% | 1.07 | 116 / 230 |
spleen | 100% | 139.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 4.32 | 45 / 45 |
adipose | 100% | 141.49 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 93.68 | 1328 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 2.80 | 28 / 29 |
muscle | 95% | 54.41 | 762 / 803 | 0% | 0 | 0 / 0 |
heart | 93% | 64.35 | 800 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 69% | 155.92 | 642 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 34% | 0.50 | 27 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0006488 | Biological process | dolichol-linked oligosaccharide biosynthetic process |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0106073 | Molecular function | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ALG10 |
Protein name | dolichyl-P-Glc:Glc2Man9GlcNAc2-PP-dolichol alpha-1,2-glucosyltransferase (EC 2.4.1.256) ALG10 alpha-1,2-glucosyltransferase Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) |
Synonyms | ALG10A |
Description | FUNCTION: Adds the third glucose residue to the lipid-linked oligosaccharide precursor for N-linked glycosylation. Transfers glucose from dolichyl phosphate glucose (Dol-P-Glc) onto the lipid-linked oligosaccharide Glc(2)Man(9)GlcNAc(2)-PP-Dol. |
Accessions | ENST00000538927.1 ENST00000541875.1 ENST00000266483.7 F5GZZ6 F5H5T2 Q5BKT4 |